Cargando…
Elevated autophagy and mitochondrial dysfunction in the Smith–Lemli–Opitz Syndrome
Smith–Lemli–Opitz Syndrome (SLOS) is a congenital, autosomal recessive metabolic and developmental disorder caused by mutations in the enzyme which catalyzes the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. Herein we show that dermal fibroblasts obtained from SLOS children display increa...
Autores principales: | Chang, Shaohua, Ren, Gongyi, Steiner, Robert D., Merkens, Louise, Roullet, Jean-Baptiste, Korade, Zeljka, DiMuzio, Paul J., Tulenko, Thomas N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231544/ https://www.ncbi.nlm.nih.gov/pubmed/25405082 http://dx.doi.org/10.1016/j.ymgmr.2014.09.005 |
Ejemplares similares
-
Smith-Lemli-Opitz-syndrome
por: Gedam, Rachana, et al.
Publicado: (2012) -
Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients
por: Koczok, Katalin, et al.
Publicado: (2021) -
Smith-Lemli-Opitz Syndrome: Bosnian and Herzegovinian Experience
por: Begic, N, et al.
Publicado: (2021) -
Smith-Lemli-Opitz-syndrome: How different is the anesthetic technique?
por: Govindarajan, Srinivasa Raghavan, et al.
Publicado: (2014) -
Smith-Lemli-Opitz Syndrome: A Case with Annular Pancreas
por: Demirdöven, Mehmet, et al.
Publicado: (2014)